Current Events

BSP PARASITES ONLINE 2021
For 2021, in place of our usual Spring Meeting, our main annual meeting will be held online over five days during the Summer (21st-25th June). We have an exciting programme of scientific content, which will be delivered through a virtual conference interface designed to maximise opportunities for interaction, through live Q&A sessions, breakout discussion rooms and virtual trade stands for our exhibitors and sponsors.

All oral presentations will need to be pre-recorded and uploaded to the site, and then broadcast during the assigned slot. Presenters will be asked to be available for a live Q&A session at the end of their assigned slot. This approach should minimise any issues associated with poor internet connections, while maintaining an element of live face to face interaction. Presenters will have the option of making their content available on the conference website for a period of 1 year, but can opt out of this without issue. Full instructions and details on all of this will be provided after you submit an abstract.

The meeting will run across two streams. Our main science stream will incorporate our usual mix of varied high quality themed scientific sessions, keynote speakers and presentations by postgraduate and postdoctoral researchers. Our second, specialist stream, will include: (1) A series of talks from the Infectious Diseases Data Observatory (IDDO; www.iddo.org); (2) Sessions focused on schistosomiasis, curated by Prof Mike Doenhoff and Prof Tony Walker; (3) A session on gender and racial equality in science, focusing on what we as parasitologists can do to address those issues.

There will also be interactive poster sessions, where delegates will have the opportunity for discussion with poster presenters (although this year we’re sorry to say that you will have to bring your own refreshments).

Click on the links above to register and/or submit an abstract!

Registration charges for the full 5 day meeting:
> Members: £90
> Students: £30
> Member in low-income countries: FREE; note also that researchers in LMIC and Least Developed Countries can join BSP FOR FREE.
> Non-members: £180

We are very pleased to announce the following confirmed invited speakers:

MAIN SCIENCE STREAM
Prof Maria-Gloria Basanez (Imperial College London)
Dr Emma Briggs (University of Glasgow)
Dr Krystyna Cwiklinski (University of Ireland Galway)
Dr Carmen Faso (University of Bern)
Prof Phillipe Guerin (Infectious Disease Data Observatory)
Prof Neil Hall (Earlham Institute)
Prof Matt Higgins (Oxford University)
Prof Achim Hoerauf (University Hospital Bonn)
Dr Rhys Jones (Aberystwyth University)
Dr Ben Makepeace (Liverpool School)
Prof Eric Morgan (Queen’s University Belfast)
Dr Russ Morphew (Aberystwyth University)
Prof Sarah Reece (University of Edinburgh)
Prof Koert Ritmijer (Médecins Sans Frontières)
Dr Claire Rogers (London School of Hygiene and Tropical Medicine)
Prof Bernd Sures (Universität Duisburg-Essen)

PARALLEL STREAM: INFECTIOUS DISEASES DATA OBSERVATORY
Prof Mitali Chatterjee (Infectious Diseases Data Observatory)
Dr Prabin Dahal (Infectious Diseases Data Observatory)
Dr Martin Walker (Royal Veterinary College)
Dr Nathalie Strub-Wourgraft (Drugs for Neglected Tropical Diseases Initiative)
Prof Sir Nicholas White (University of Oxford)

PARALLEL STREAM: TOWARDS GENDER AND RACIAL EQUALITY IN SCIENCE
Dr Regina Cordy (Wake Forest University)
Dr Elisabeth English (University of Pennsylvania)
Prof Elena Gomez-Diaz (Institute of Parasitology and Biomedicine Lopez-Neyra)
Prof Debbie Smith (University of York)
Prof Santuza Teixeira (Federal University of Minas Gerais)

PARALLEL STREAM: SCHISTOSOMIASIS
Prof Coen Adema (University of New Mexico)
Prof Matt Berriman (Wellcome Sanger Institute)
Dr Conor Caffrey (University of California San Diego)
Prof Dan Colley (University of Georgia)
Dr Jim Collins (University of Texas Southwestern Medical Centre)
Prof Christoph Grevelding (Justus Liebig Universitat Giessen)
Prof Peter Hotez (Baylor College of Medicine)
Prof Andrew McDonald (University of Manchester)
Prof Joanne Webster (Imperial College London)

<< less

BSP PARASITES ONLINE 2021
For 2021, in place of our usual Spring Meeting, our main annual meeting will be held online over five days during the Summer (21st-25th June). We have an exciting programme of scientific content, which will be delivered through a virtual conference interface designed to more >>

15th Biosimilars Congregation 2021
23rd - 24th June 2021, Virtual Conference (Time Zone - BST)
Our 15thBiosimilars Congregation 2021 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in regulatory science and regulatory policy in the EU and other international jurisdictions. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.
DELEGATE REGISTRATION:
Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
EARLY BIRD PRICE
1 Delegate @ £300 +VAT (Valid Till 17th May 2021)
3 Delegates @ £700 +VAT (Valid Till 17th May 2021)
STANDARD PRICE
1 Delegate @ £500 +VAT (Valid From 18th May 2021)
3 Delegates @ £1200 +VAT (Valid From 18th May 2021)
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• FREDRIK SUNDBERG, Global Director, Strategic Technology Partnership, Cytiva (Formerly GE Life Sciences)
• RAJESH DESIKAN, Vice President & Head, US Marketing, Oncology & Immunology Biosimilars, Fresenius-Kabi
• JULIE MARECHAL JAMIL, Director Biosimilar Policy & Science, Medicines for Europe
• MATTHEW TURNER, Senior Director Government Affairs and Policy Biosimilars Europe, Asia, Latam & Canada, Fresenius Kabi
• CECIL NICK, Vice President, Parexel
• ANNA AILLERIE, Brand Management Lead, Europe, Dr Reddy’s Laboratories SA
• MIGUEL NAVARRETE OLMEDO, Hospital & Biosimilars Commercial Director, STADA Arzneimittel
• LOUIS BOON, CSO, Polpharma Biologics
• HANMANT BARKATE, Vice President & Head Medical Services (India, MEA), Glenmark
• SWEETY MATHEW, Regulatory Affairs, Biocon
• MARTA BALDRIGHI, Policy & Science Officer, Medicines for Europe
• NIKLAS EKMAN, Head of the Biological Section, Finnish Medicines Agency
• OMAR ALI, Pharmacist Consultant, QIPP Adviser Payer Network
• RENE ANOUR, Senior Clinical Expert/Head of National Scientific Advice, Austrian Medicines & Medical Devices Agency (AGES)
• BER OOMEN, Executive Director, ESNO (European Specialist Nurses Organisations)
• MICHEL MIKHAIL, International Expert in Biosimilars, Global Expert in Regulatory Affairs, Michel Mikhail
• LENNEKE DE WINTER, Senior Scientist USP, Polpharma Biologics
• JAAP WIELING, CSO, BiosanaPharma
• JAKOB LANGE, Senior Director Delivery Systems, Ypsomed
• ANDREAU SOLDEVILA, Founder and CEO, Syna Therapeutics
• INGRID SCHWARZENBERGER, Senior Regulatory Consultant, Independent Consultant
• BERT THOMAS, Senior Vice President, Business Development, Bio-Thera Solutions
• SANDY EISEN, Chief Medical Officer, Frontline Pharma Consulting Ltd
• ZIQUN HAN, Director, Zen Medical Science
• MARIE MANLEY, Partner, Head of the UK Life Sciences, Sidley Austin
• ALEXANDER ROUSSANOV, Life Sciences Regulatory and Privacy Lawyer, Arnold & Porter
• ROBERT A. JOHNSTONE, Board Member, International Alliance of Patients Organisations
• JOHAN DE MUNTER, Assistant Nurse Manager Cancer Center, President, University Hospital Ghent, European Oncology Nursing Society
• MARC MARTENS, Partner, Bird & Bird
KEY THEMES:
• Strategies for market access and expansion by identifying key changes and future projections
• Understanding the biosimilars opportunity for pharma companies
• Consequences of Brexit & this pandemic situation on Biosimilars
• Current Challenges and Opportunities for future- Strategies in developing Biosimilars
• A Clinician ?s Guide to Biosimilars in Oncology: understanding the Science of Extrapolation and Interchangeability
• Biosimilars – Pricing & Market access - Bringing it faster into market
• GMP, GCP, QC & R&D
• Current challenges and opportunities - strategies to develop Biosimilars
• Payer perspective on biologics and Biosimilars
• Biosimilar Interchangeability: The newest regulation
• Biosimilar - Physicians and Patients perspective
• CMC, Preclinical and clinical considerations for Biosimilars and Follow-on Biologics
• Impact of Technology
• Commercial landscape & market access for Biosimilars: Predicts to prepare for a successful tomorrow
• Hear case studies on biosimilars drug development from pre-clinical to clinical and the various testing required such as immunogenicity and bio-similarity tests
• Research-based industry Biosimilar strategies
• Considerations for the analytical similarity assessments when designing a Biosimilar development program
• Determining the right investments & potential returns from Biosimilars
• Latest developments in regulation to increase speed of entry and compliance
• Future of next generation biosimilars
• Be part of a major networking opportunity
Get more from the event, enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.
<< less

15th Biosimilars Congregation 2021
23rd - 24th June 2021, Virtual Conference (Time Zone - BST)
Our 15thBiosimilars Congregation 2021 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in more >>

4th Annual Pharma Pricing, Reimbursement & Market Access 2021
29th - 30th June 2021, Virtual Conference (Time Zone - BST)
This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU, it gives me great pleasure in welcoming all of you to the Virtue Insight’s 3rd Annual Pharma Pricing, Reimbursement & Market Access 2020. I wish and pray that all our efforts will be beneficial to our industry and to our country at large.
DELEGATE REGISTRATION:
Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
EARLY BIRD PRICE
1 Delegate @ £300 +VAT (Valid Till 24th May 2021)
3 Delegates @ £700 +VAT (Valid Till 24th May 2021)
STANDARD PRICE
1 Delegate @ £500 +VAT (Valid From 25th May 2021)
3 Delegates @ £1200 +VAT (Valid From 25th May 2021)
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• GERGANA ZLATEVA, Vice President and Business Unit Lead, Oncology, Patient & Health Impact, Pfizer
• VIVECA PARKER, Assistant US Attorney, Dept of Justice
• ADAM LEVYSOHN, Head of Biogen Value & Access Alzheimer’s Disease, Biogen
• MARIA ALEJANDRA BLANC, Director - Regulatory Affairs, Abbvie
• MARIO OUWENS, Senior Statistical Science Director, Group director Medical & Payer Evidence Statistics, AstraZeneca
• LAURENE REDDING, Head, Value, Access & Policy, BeiGene
• LARA PIPPO, Head of Market Access & Government Affairs, CSL Behring
• SAMUEL MURPHY, VP & Head of International BD, Shenzhen Salubris Pharmaceuticals
• VIJAY REDDY, Senior Director - Global Market Access Strategy, Biocon Biologics
• ALEEN HOSDAGHIAN, Brand Lead, US Immunology, UCB Pharma
• JESPER BJERGGREN, European Market Access Lead, Digital Health, Teva Pharmaceuticals
• OMAR ALI, Pharmacist Consultant, QIPP Adviser Payer Network
• SARAH GARNER, Acting Program Manager - Access to Medicines and Health Products, WHO
• MARCO MARCHETTI, Director, National Center for HTA, Istituto Superiore di Sanità
• MARTIN SCHUCHARDT, Global Market Access & Pricing Lead, Almirall
• NURIYA MUSINA, Head of Development, Center of Healthcare Quality Assessment and Control, Ministry of Health of The RF
• ROBERT POPOVIAN, CEO, Former VP, Gov Relations, Conquest Advisors, Pfizer
• LUC BOILEAU, President - Director General, INESSS
• ISABELLE GANACHE, Director, INESSS
• OLIVER LEATHAM, VP, Global Head of Commercial Strategy and EU Value & Access, Certara
• MARTIJN NEGEN, VP Commercial Strategy, AM Pharma
• IGOR RUDYCHEV, Vice President, Enterprise Analytics, Horizon Therapeutics
• ROSEMARY JOSE, Senior Director, Strategic Market Access, Open Health
• JUAN VERGEZ, Head of Marketing & Corporate Communications, Arvelle Therapeutics
• ERIN MISTRY, SVP Payer Strategy, Government Affairs and Trade, Cormedix
• REED STEPHENS, Partner, Winston & Strawn
• TIM EPPLE, Principal, Financial Services, Avalere Health
• ALEXANDER NATZ, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
• MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalition
• SANDY EISEN, Chief Medical Officer, Frontline Pharma Consulting Ltd
Plus more joining soon
KEY THEMES DISCUSSED IN THIS CONFERENCE:
• Preparing your best market access strategy
• EU and US policy challenges for market access: Stepping ahead
• Unrivalled opportunity to expose and address the market access challenges facing the industry
• Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
• Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
• Understanding - payers’ perspective
• Advocating and collaborating with payers for value in a new era
• Creating a robust patient services and reimbursement support program for biosimilar products
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Understand how price affects market access and learn on how to set prices for optimal access and returns.
• New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• Impact of social media and digital analytics
• Developing risk-sharing reimbursement models and value based pricing
• Patient engagement and adherence within the environment
• Explaining how to use the data sources and observational research for effective safety analysis
• Dwell ahead of regulatory developments & improving your strategies in a cost effective way in EU, US
• Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
WHO SHOULD ATTEND:
Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of:
Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the virtual exhibition area. Expand your knowledge of the latest business models and strategies in the high-level conference.


<< less

4th Annual Pharma Pricing, Reimbursement & Market Access 2021
29th - 30th June 2021, Virtual Conference (Time Zone - BST)
This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current more >>

The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical stages: 1) Identifying your target. 2) Drugging your target. 3) Gaining clinical insights. These session themes will run sequentially and blend the most exciting science from early career researchers, commercial organisations and key academic, clinical and industry leaders in the field. In addition, an interactive panel discussion will provide the opportunity to share perspectives on some of the most current and innovative routes though which to translate scientific ideas into impactful therapies. Topics in scope for this scientific program will include:

Target Identification & Validation

• Disease-centric biology insights & dealing with increasingly complex target biology
  
• Leveraging emerging platform technologies
  
• Deconvoluting target hit lists

Drugging your target

• How new drug formats are changing drug discovery
  
• New concepts in pharmacology – poly-pharmacology, cellular kinetics etc
  
• New models of collaborative drug discovery (panel discussion topic)

Clinical insights

• Experimental medicine studies with proprietary and/or essential medicines
  
• Examples of successful clinical translation of new medicine concepts
  
• Bringing patient data insights into the discovery pipeline

Through this joint meeting, being organised by ELRIG and the BPS, we aim to bring together the research community working in the field of new medicine creation with interests in developing their translational research ideas and applying novel technologies and means of collaboration to address critical clinical needs. Join scientists from academia, pharma, biotech and CRO’s either in person or online to hear talks given by speakers at the cutting edge of their field and gain strategic insights into solutions for increasing the success of your therapeutic ideas. << less

The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical more >>

3rd Annual Pharma Packaging, Labelling, Serialization, Track & Trace 2021
“Securing your Supply Chain and Quality Management”
15th July 2021, Virtual Conference (Time Zone - IST)
Virtue Insight is delighted to announce its 3rd Annual Pharma Packaging, Labelling, Serialization, Track & Trace 2021 to be held on 15th July 2021(Virtual Conference). Get in touch with decision makers not only from the Pharma and Healthcare but also from the Chemical and Food Industry at Packaging and Labelling Conference. Benefit from our deep expert knowledge on Track & Trace and Serialization Solutions and optimize your supply chain with help of our future-proof solutions, partners, and the profound insights of our speakers. Discover how Pharma Packaging Labelling, Serialization and Track & Trace improves consumer safety and supply chain transparency, find out what benefits Pharma Packaging delivers beyond legal compliance, and learn how its help grow your business.
DELEGATE REGISTRATION:
E-mail - kavitha@virtueinsight.co.in or Call M: +91 9361957193
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
• Early Bird Price (Valid Till 11th June 2021) – (INR 6,000 + GST (18%) per delegate)
• Standard Price (Valid From 12th June 2021) – (INR 8,000 + GST (18%) per delegate)
• For more than 5 delegates please let us know your interests.
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• MARCEL DE GRUTTER, PM Serialization & Liaison Regulatory & Government Affairs, Abbott (Netherlands)
• HEIKO TREFZGER, Product Manager, Business Analyst, Innovation Representative, Roche (Germany)
• S.R. SALUNKHE, Former Assistant Commissioner, FDA Maharashtra
• CHAKRAVARTHI AVPS, Global Ambassador, Hon Advisor and Director on Board - Pharmaceutical Export Promotion Council, Govt of India, World Packaging Organisation
• PRASAD S. DESHPANDE, Senior Vice President& Global Head – Supply Chain Management, Biocon
• SUDHIR MOHAN BANSAL, Vice President & India Head of Supply Chain Management, Pfizer
• KRISHNA SAI T, Associate Vice President, Biocon
• MAHESH MURTHY, Sr. Director of Operations Medical Device, Biocon
• VAIBHAV KULKARNI, Director - Regulatory Affairs, Abbott Nutrition
• VIPUL JAIN, Associate Director, Cipla
• GAURAV BHATIA, Associate Director - Supply Chain, Cipla
• PRABIR DAS, Head of Packaging Technical Services, OSD (India), Mylan Laboratories
• KAUSTUBH KULKARNI, Senior Manager - Packaging Development, Wockhardt
• SHIVAJICHAKRABORTY, Asst. General Manager, Fresenius Kabi
• AJAY BAPAT, Independent Pharma Packaging Consultant
• VICKRAM SRIVASTAVA, Head of Planning - Supply Chain Management, Ipca Laboratories
• SOUMYANATH MISHRA, Head-Packaging Development, Mankind Research Centre
• ANAHITA KARANDE, Head - Packaging Development & Procurement, Alembic Pharmaceuticals
• MARIAPPAN N, Chief Manager and Global Labeling, Piramal
• KINJAL PARIKH, Sr Research Assistant Formulation & Development, Baxter
• BHARAT BHUSHAN RATHI, Head Logistics, Mankind Research Centre
• RAMESHWAR VERMA, Senior Officer of Track and Trace and Serialization, Intas Pharmaceuticals
• KAZI MASUD HASAN, Team Lead - Packaging Development, Dr. Reddy's Laboratories
KEY THEMES DISCUSSED:
• Smart packaging and e-labelling advancements
• Knowing what smart packaging is and how it relates to the labeling process is important.
• Addressing some of the most challenging problems in pharmaceutical labeling and package design
• How major pharma companies have managed the challenging task of manufacturing labels, records, and packaging.
• Smart packaging for pharma industries – How can we make packaging truly intelligent?
• Does the future of pharmaceutical packaging seem to be bright? Why smart packaging will affect the pharmaceutical industry’s future.
• Addressing the future of life sciences labeling with technology and transparency
• Addressing the major changes in the way we manufacture goods, as well as the digitization of manufacturing
• Implementation and aggregation of serialization technology and tools
• Focusing on the introduction of serialization and discussing some of the problems, solutions, and takeaways
• Track & Trace - Serialization is the new normal? Discussing operations in a serialized world
• Addressing serialization’s side effects, including the loss of productivity in packaging and warehouse operations.
• Packaging and labeling developments in the global regulatory environment
• Focusing on global regulatory patterns, standards, and guidelines, as well as their potential consequences for packaging and labeling
• Meeting your needs while complying with regulatory requirements
• How the pharma industry is keeping up with changing labelling regulations and compliance?
• Be part of a major networking opportunity
WHO SHOULD ATTEND AND WHO YOU’LL MEET:
CEO's, CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:
Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Serialisation, Track and Trace – Solution providers, Brand – protection, enforcement, security, integrity and management companies, Drug regulatory agencies, customs and police, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection, Non-governmental organizations (NGOs) active in healthcare, Patients’ representatives, Healthcare research organizations, Pharmaceutical associations, Anti-counterfeiting organizations, Packaging, labelling and converting companies, Authentication technology suppliers, Anti-counterfeiting service suppliers – IP specialists, investigators, lawyers.
CERTIFICATION:
E-Certificate of attendance would be provided to attendees on request, upon completion of conference
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
<< less

3rd Annual Pharma Packaging, Labelling, Serialization, Track & Trace 2021
“Securing your Supply Chain and Quality Management”
15th July 2021, Virtual Conference (Time Zone - IST)
Virtue Insight is delighted to announce its 3rd Annual Pharma Packaging, Labelling, Serialization, Track & Trace more >>

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021.

There will be two workshops os on 28th September, the day before the Conference starts.

Best Practices in the Field of Electronic Registry Design and Operation

Economic Assessment of International Commercial Law Reform

Attendance at the workshops on the 28th September is free but by invitation only.

See a map of the conference locations here.

Car parking is available a short walk away from Robinson College, where the Conference will be held, at a cost of £10 per day and can be booked during the registration process. Nearby on-street parking may be used but it is usually hard to find.

Accommodation at Robinson College will be available. These are good quality, en-suite student rooms and cost £90 per night for bed and breakfast. These can be booked from 1st July here

Some good quality hotels in Cambridge are
The Graduate
Hilton Cambridge City Centre
Hotel du Vin
University Arms
The Clayton Hotel
The Fellowes House
<< less

This year’s conference will be held on Wednesday 29th and Thursday 30th of September 2021.

There will be two workshops os on 28th September, the day before the Conference starts.

Best Practices in the Field of Electronic Registry Design and Operation

Economic Assessment more >>